|
|
|
|||||||
|
|||||||||
J Biol Chem, Vol. 274, Issue 24, 16694-16700, June 11, 1999
From the
Targeted Disruption of the
2 Adrenergic Receptor Gene
,
,,, and**
Department of Molecular and
Cellular Physiology, ** Division of Cardiovascular Medicine,
Department of Pediatrics, the Howard
Hughes Medical Institute, Stanford University,
Stanford, California 94305 and the ¶ Department of Molecular
Pharmacology, Roche Bioscience, Palo Alto, California 94304
-Adrenergic receptors (-ARs) are members of
the superfamily of G-protein-coupled receptors that mediate the effects
of catecholamines in the sympathetic nervous system. Three distinct
-AR subtypes have been identified (1-AR, 2-AR, and 3-AR).
In order to define further the role of the different -AR subtypes,
we have used gene targeting to inactivate selectively the 2-AR gene
in mice. Based on intercrosses of heterozygous knockout (2-AR +/
)
mice, there is no prenatal lethality associated with this mutation. Adult knockout mice (2-AR /) appear grossly normal and are fertile. Their resting heart rate and blood pressure are normal, and
they have a normal chronotropic response to the -AR agonist isoproterenol. The hypotensive response to isoproterenol, however, is
significantly blunted compared with wild type mice. Despite this defect
in vasodilation, 2-AR / mice can still exercise normally and
actually have a greater total exercise capacity than wild type mice. At
comparable workloads, 2-AR / mice had a lower respiratory
exchange ratio than wild type mice suggesting a difference in energy
metabolism. 2-AR / mice become hypertensive during exercise and
exhibit a greater hypertensive response to epinephrine compared with
wild type mice. In summary, the primary physiologic consequences of the
2-AR gene disruption are observed only during the stress of exercise
and are the result of alterations in both vascular tone and energy metabolism.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. V. N. Bacurau, M. A. Jardim, J. C. B. Ferreira, L. R. G. Bechara, C. R. Bueno Jr., T. C. Alba-Loureiro, C. E. Negrao, D. E. Casarini, R. Curi, P. R. Ramires, et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training J Appl Physiol, May 1, 2009; 106(5): 1631 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Nguyen, R. Lin, S. Parra, O. Omoluabi, N. A. Hanania, M. J. Tuvim, B. J. Knoll, B. F. Dickey, and R. A. Bond From the Cover: {beta}2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model PNAS, February 17, 2009; 106(7): 2435 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-Q. Han, Y.-B. Ouyang, L. Xu, R. Agrawal, A. J. Patterson, and R. G. Giffard Postischemic Brain Injury Is Attenuated in Mice Lacking the {beta}2-Adrenergic Receptor Anesth. Analg., January 1, 2009; 108(1): 280 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Ghoghawala, M. J. Mannis, C. E. Pullar, M. I. Rosenblatt, and R. R. Isseroff {beta}2-Adrenergic Receptor Signaling Mediates Corneal Epithelial Wound Repair Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1857 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cabou, P. D. Cani, G. Campistron, C. Knauf, C. Mathieu, C. Sartori, J. Amar, U. Scherrer, and R. Burcelin Central Insulin Regulates Heart Rate and Arterial Blood Flow: An Endothelial Nitric Oxide Synthase Dependent Mechanism Altered During Diabetes Diabetes, December 1, 2007; 56(12): 2872 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shi, Z. Wu, N. Cui, W. Shi, Y. Yang, X. Zhang, A. Rojas, B. T. Ha, and C. Jiang PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1205 - R1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Bao, C. M. Lu, F. Liu, Y. Gu, N. D. Dalton, B.-Q. Zhu, E. Foster, J. Chen, J. S. Karliner, J. Ross Jr, et al. Epinephrine Is Required for Normal Cardiovascular Responses to Stress in the Phenylethanolamine N-Methyltransferase Knockout Mouse Circulation, August 28, 2007; 116(9): 1024 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Emeny, D. Gao, and D. A. Lawrence beta1-Adrenergic Receptors on Immune Cells Impair Innate Defenses against Listeria J. Immunol., April 15, 2007; 178(8): 4876 - 4884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Ebert and D. G. Taylor Catecholamines and development of cardiac pacemaking: An intrinsically intimate relationship Cardiovasc Res, December 1, 2006; 72(3): 364 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Snyder, S. T. Turner, M. J. Joyner, J. H. Eisenach, and B. D. Johnson The Arg16Gly polymorphism of the {beta}2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans J. Physiol., August 1, 2006; 574(3): 947 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ahn, B. Dubern, C. Lubrano-Berthelier, K. Clement, and G. Karsenty Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency Endocrinology, July 1, 2006; 147(7): 3196 - 3202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Poole, H. Snieder, H. C. Davis, and F. A. Treiber Anger suppression and adiposity modulate association between ADRB2 haplotype and cardiovascular stress reactivity. Psychosom Med, March 1, 2006; 68(2): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Snyder, K. C. Beck, N. M. Dietz, J. H. Eisenach, M. J. Joyner, S. T. Turner, and B. D. Johnson Arg16Gly polymorphism of the {beta}2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans J. Physiol., February 15, 2006; 571(1): 121 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ecker, C.-C. Lin, J. Powers, B. K. Kobilka, A. M. Dubin, and D. Bernstein Effect of targeted deletions of {beta}1- and {beta}2-adrenergic-receptor subtypes on heart rate variability Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H192 - H199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bernstein, G. Fajardo, M. Zhao, T. Urashima, J. Powers, G. Berry, and B. K. Kobilka Differential cardioprotective/cardiotoxic effects mediated by {beta}-adrenergic receptor subtypes Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2441 - H2449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tavernier, M. Jimenez, J.-P. Giacobino, N. Hulo, M. Lafontan, P. Muzzin, and D. Langin Norepinephrine Induces Lipolysis in {beta}1/{beta}2/{beta}3-Adrenoceptor Knockout Mice Mol. Pharmacol., September 1, 2005; 68(3): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Bachman, T. G. Hampton, H. Dhillon, I. Amende, J. Wang, J. P. Morgan, and A. N. Hollenberg The Metabolic and Cardiovascular Effects of Hyperthyroidism Are Largely Independent of {beta}-Adrenergic Stimulation Endocrinology, June 1, 2004; 145(6): 2767 - 2774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Mutlu, V. Dumasius, J. Burhop, P. J. McShane, F. J. Meng, L. Welch, A. Dumasius, N. Mohebahmadi, G. Thakuria, K. Hardiman, et al. Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on {beta}2-Adrenergic Receptor Signaling Circ. Res., April 30, 2004; 94(8): 1091 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Gobran and S. A. Rooney Pulmonary surfactant secretion in briefly cultured mouse type II cells Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L331 - L336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hoeks, M. A. van Baak, M. K. C. Hesselink, G. B. Hul, H. Vidal, W. H. M. Saris, and P. Schrauwen Effect of {beta}1- and {beta}2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E775 - E782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiang and B. Kobilka The PDZ-binding motif of the {beta}2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes PNAS, September 16, 2003; 100(19): 10776 - 10781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Lowell and E. S. Bachman {beta}-Adrenergic Receptors, Diet-induced Thermogenesis, and Obesity J. Biol. Chem., August 8, 2003; 278(32): 29385 - 29388. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Podojil and V. M. Sanders Selective Regulation of Mature IgG1 Transcription by CD86 and {beta}2-Adrenergic Receptor Stimulation J. Immunol., May 15, 2003; 170(10): 5143 - 5151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bernstein Exercise assessment of transgenic models of human cardiovascular disease Physiol Genomics, May 13, 2003; 13(3): 217 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiang, E. Devic, and B. Kobilka The PDZ Binding Motif of the beta 1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes J. Biol. Chem., September 6, 2002; 277(37): 33783 - 33790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiang, V. O. Rybin, S. F. Steinberg, and B. Kobilka Caveolar Localization Dictates Physiologic Signaling of beta 2-Adrenoceptors in Neonatal Cardiac Myocytes J. Biol. Chem., September 6, 2002; 277(37): 34280 - 34286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2002; 23(4): 594 - 597. [Full Text] [PDF]
|
|
|
|
|
|
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Eckhart, T. Ozaki, H. Tevaearai, H. A. Rockman, and W. J. Koch Vascular-Targeted Overexpression of G Protein-Coupled Receptor Kinase-2 in Transgenic Mice Attenuates beta -Adrenergic Receptor Signaling and Increases Resting Blood Pressure Mol. Pharmacol., April 1, 2002; 61(4): 749 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chruscinski, M. E. Brede, L. Meinel, M. J. Lohse, B. K. Kobilka, and L. Hein Differential Distribution of beta -Adrenergic Receptor Subtypes in Blood Vessels of Knockout Mice Lacking beta 1- or beta 2-Adrenergic Receptors Mol. Pharmacol., November 1, 2001; 60(5): 955 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Eckhart and W. J. Koch Transgenic Studies of Cardiac Adrenergic Receptor Regulation J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-T. TSENG, R. KOPEL, J. P. STABILA, B. G. MCGONNIGAL, T. T. NGUYEN, P. A. GRUPPUSO, and J. F. PADBURY {beta}-Adrenergic receptors ({beta}AR) regulate cardiomyocyte proliferation during early postnatal life FASEB J, September 1, 2001; 15(11): 1921 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Devic, Y. Xiang, D. Gould, and B. Kobilka beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Georgakopoulos and D. A Kass Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart J. Physiol., July 15, 2001; 534(2): 535 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-J. Du Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice Cardiovasc Res, June 1, 2001; 50(3): 443 - 453. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Kasprowicz, A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. Sharpe, and V. M. Sanders Stimulation of the B Cell Receptor, CD86 (B7-2), and the {beta}2-Adrenergic Receptor Intrinsically Modulates the Level of IgG1 and IgE Produced per B Cell J. Immunol., July 15, 2000; 165(2): 680 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Bray, J. Krushkal, L. Li, R. Ferrell, S. Kardia, C. F. Sing, S. T. Turner, and E. Boerwinkle Positional Genomic Analysis Identifies the {beta}2-Adrenergic Receptor Gene as a Susceptibility Locus for Human Hypertension Circulation, June 27, 2000; 101(25): 2877 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction Circ. Res., November 26, 1999; 85(11): 1092 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tang, L. A. Hu, W. E. Miller, N. Ringstad, R. A. Hall, J. A. Pitcher, P. DeCamilli, and R. J. Lefkowitz Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta 1-adrenergic receptor PNAS, October 26, 1999; 96(22): 12559 - 12564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Rohrer, A. Chruscinski, E. H. Schauble, D. Bernstein, and B. K. Kobilka Cardiovascular and Metabolic Alterations in Mice Lacking Both beta 1- and beta 2-Adrenergic Receptors J. Biol. Chem., June 11, 1999; 274(24): 16701 - 16708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Hu, Y. Tang, W. E. Miller, M. Cong, A. G. Lau, R. J. Lefkowitz, and R. A. Hall beta 1-Adrenergic Receptor Association with PSD-95. INHIBITION OF RECEPTOR INTERNALIZATION AND FACILITATION OF beta 1-ADRENERGIC RECEPTOR INTERACTION WITH N-METHYL-D-ASPARTATE RECEPTORS J. Biol. Chem., December 1, 2000; 275(49): 38659 - 38666. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |